Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

A Multicenter Study to Evaluate Efficacy and Safety

A multicenter, randomized, double-blind, phase Ⅳ study to evaluate the long-term efficacy and safety of Pitavastatin/Ezetimibe and Pitavastatin in patients with hypercholesterolemia with elevated triglycerides

A multicenter study to evaluate efficacy and safety

Inclusion Criteria:

• Patients with hypercholesterolemia
• Patients diagnosed with metabolic syndrome or type 2 diabetes mellitus, and presenting with elevated LDL-C

Exclusion Criteria:

• New-onset acute cardio-cerebrovascular disease
• Severe hepatic impairment
• Active liver disease